BDUUF vs LLY: Which Stock is Better?
Side-by-side comparison of Bangkok Dusit Medical Services Public Company Limited and Eli Lilly & Co in 2026
BDUUF
Bangkok Dusit Medical Services Public Company Limited
$0.65
LLY
Eli Lilly & Co
$919.90
Key Metrics Comparison
| Metric | BDUUF | LLY | Winner |
|---|---|---|---|
| Market Cap | $10.33B | $823.33B | LLY |
| P/E Ratio | 21.67 | 40.15 | BDUUF |
| EPS (TTM) | $0.03 | $22.91 | LLY |
| Revenue Growth | 0.0% | 0.4% | LLY |
| Gross Margin | 37.1% | 83.0% | LLY |
Analyze BDUUF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BDUUF or LLY a better investment?
Comparing BDUUF and LLY: Bangkok Dusit Medical Services Public Company Limited has a market cap of $10.33B while Eli Lilly & Co has $823.33B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BDUUF and LLY?
BDUUF (Bangkok Dusit Medical Services Public Company Limited) and LLY (Eli Lilly & Co) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BDUUF or LLY?
Based on P/E ratios, BDUUF trades at a lower multiple (21.7x vs 40.2x).
Which is growing faster: BDUUF or LLY?
LLY has higher revenue growth at 0.4% vs 0.0% for BDUUF.
Which company is more profitable: BDUUF or LLY?
Eli Lilly & Co (LLY) has higher gross margins at 83.0% compared to 37.1% for BDUUF.
Which is the larger company: BDUUF or LLY?
Eli Lilly & Co (LLY) is larger with a market cap of $823.33B compared to $10.33B for BDUUF.
Should I buy BDUUF or LLY in 2026?
Both BDUUF and LLY have investment merit. BDUUF trades at $0.65 while LLY trades at $919.90. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BDUUF and LLY stock?
Key differences: Market Cap ($10.33B vs $823.33B), P/E Ratio (21.7x vs 40.2x), Revenue Growth (0.0% vs 0.4%), Gross Margin (37.1% vs 83.0%).